Aethlon Medical Finalizes $4.0M Offering with 237% Immediate Dilution and Warrants
AEMD sits 20% above its 52-week low of $0.64 on light trading volume (0.1× avg).
Summary
Aethlon Medical has finalized a best-efforts offering to raise approximately $3.335 million, involving significant dilution of 237.6% immediately and potentially up to 485% if all associated warrants are exercised, as the company addresses its going concern status.
Key Events · Financing and Capital Events · AEMD
-
Capital Raise Finalized
Aethlon Medical finalized a best-efforts offering to raise approximately $3.335 million in net proceeds, critical for its operations.
-
Immediate Share Dilution
The offering involves the sale of 5,633,009 shares of common stock or pre-funded warrants, representing an immediate dilution of 237.6% to existing shareholders based on current outstanding shares.
-
Extensive Warrant Issuance
Accompanying the offering are warrants to purchase an additional 5,633,009 shares at $0.71, plus 225,320 placement agent warrants, potentially leading to a total dilution of 485% if all warrants are exercised.
-
Offering Priced at Discount
The offering is priced at $0.71 per unit (common stock/pre-funded warrant plus accompanying warrant), which was the closing price on July 2, 2026, but is below the current market price of $0.7699.
Analysis · AEMD · Industrial Applications And Services
This 424B3 filing finalizes the terms of a best-efforts offering, providing Aethlon Medical with approximately $3.335 million in net proceeds. While this capital infusion is crucial for the company, which recently disclosed substantial doubt about its ability to continue as a going concern, the offering comes at an extremely high cost to existing shareholders. The sale of 5,633,009 shares or pre-funded warrants represents an immediate dilution of 237.6% to current shareholders. Furthermore, the issuance of an equal number of common warrants and additional placement agent warrants could lead to a total potential dilution of 485% if all are exercised. The offering price of $0.71 per unit, while matching the stock's price on July 2, 2026, is below the current market price, indicating a concessionary financing structure.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 46.1% of the 284 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AEMD was trading at $0.77 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $0.64 to $27.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.